Send me a link:

*Text messaging rates may apply.

 Dow Down 1.33% Nasdaq Down 1.58%

Celgene Corporation (CELG)

-NasdaqGS
87.67 Down 0.67(0.76%) 2:01PM EDT - Nasdaq Real Time Price
Prev Close:88.34
Open:87.87
Bid:87.66 x 100
Ask:87.70 x 100
1y Target Est:99.78
Beta:1.11
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:87.11 - 88.41
52wk Range:65.76 - 90.50
Volume:2,376,785
Avg Vol (3m):4,894,640
Market Cap:70.21B
P/E (ttm):27.90
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.76%70.21B
JNJDown 1.27%285.74B

Key Statistics

Forward P/E (1 yr):17.89
P/S (ttm):10.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback